Literature DB >> 1657467

Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals.

L Sterin-Borda1, G Gorelik, E S Borda.   

Abstract

The interaction of the IgG from Trypanosoma cruzi-infected mice (chagasic IgG) with cardiac cholinergic receptors by means of specific radioligand binding and by production of cholinergic-mediated cellular transmembrane signals was characterized. Chagasic IgG inhibited, in a noncompetitive manner, the binding of [3H]quinuclidinyl benzilate to the cardiac membrane. Moreover, chagasic IgG could modify all of the muscarinic cholinergic effects mediated by a G regulatory protein, i.e., decrement of atria contractility, inhibition of cAMP, or activation of the turnover of phosphoinositides via phospholipase C. The cGMP production was also increased by the antibody. The data demonstrated that chagasic IgG interacting with cardiac muscarinic cholinergic receptor triggers the biological effects associated with cholinergic-mediated cellular transmembrane signals. The implications of the results in the pathogenesis of Chagas' myocarditis are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657467     DOI: 10.1016/s0090-1229(05)80010-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  16 in total

Review 1.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

Review 2.  Rational design of dualsteric GPCR ligands: quests and promise.

Authors:  Klaus Mohr; Christian Tränkle; Evi Kostenis; Elisabetta Barocelli; Marco De Amici; Ulrike Holzgrabe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  Involvement of nitric oxide synthase and protein kinase C activation on chagasic antibodies action upon cardiac contractility.

Authors:  L Sterin-Borda; G Cremaschi; A M Genaro; A V Echagüe; J C Goin; E Borda
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 4.  Characterization of anti-heart M2 muscarinic receptor antibodies--a combined clinical and experimental study.

Authors:  M L Fu
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 5.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 6.  The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

7.  Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome.

Authors:  E Borda; J J Camusso; C Perez Leiros; S Bacman; O Hubscher; R Arana; L Sterin-Borda
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

8.  Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease.

Authors:  E Mahler; J Hoebeke; M J Levin
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

9.  Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.

Authors:  Ciria C Hernandez; Jose H Nascimento; Elen A Chaves; Patricia C Costa; Masako O Masuda; Eleonora Kurtenbach; Antonio C Campos DE Carvalho; Luis E Gimenez
Journal:  J Recept Signal Transduct Res       Date:  2008       Impact factor: 2.092

10.  Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients.

Authors:  J C Goin; G Venera; M Biscoglio de Jiménez Bonino; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.